ArticleMolecular cancer therapeutics2018

Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer.

Fengyi Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.